Clinical and MRI features associated with remission following biological therapy in axial spondyloarthritis.
Azuaga AB · 2026 · Clinical rheumatology
Reading the original? How to read a paper.
What this paper found
In 41 people starting their first biologic for axial spondyloarthritis, those whose baseline MRI showed more erosion of the sacroiliac joints, and more active inflammation, were the most likely to reach remission by 16 weeks. The damage and inflammation a scan shows before treatment may help predict who will do best on a biologic, which is the opposite of assuming a worse-looking scan means a worse outlook.
Why this is on the map
Small, but one of few studies linking pre-treatment MRI features to biologic response rather than to diagnosis.
On the map under this thread
DOI: 10.1007/s10067-026-08380-9 · opens in a new tab. The full paper is on the publisher’s site, not here.
Related papers on the board
Papers sharing one or more threads with this one.
Long-term functional and radiological outcomes among survivors of ankylosing spondylitis-associated cervical spine fractures: a cross-sectional follow-up study.
North American Spine Society journal
Among 97 survivors of neck fractures linked to ankylosing spondylitis, followed for a median of four years, most lived independently with mild neck pain and low disability, 96 percent of fractures had healed solidly, and half of those with spinal cord injury recovered fully. These fractures are dangerous at the time, but for those who come through them the long-term picture is better than most people would expect.
Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated with High Structural Damage in Ankylosing Spondylitis
Arthritis & Rheumatology
Measuring hundreds of blood proteins in people with ankylosing spondylitis, researchers found a five-protein signature, driven by platelet and tissue-remodelling proteins rather than classic inflammation markers, that identified those with heavy structural damage with high accuracy in a separate validation group. Bone damage in AS seems to run partly on a different track from inflammation, and a blood test for it looks feasible.
Preconception, pregnancy and postpartum periods in spondyloarthritis: Unmet needs and challenges from a patients and rheumatologists surveys
Joint Bone Spine
Surveys of French women with spondyloarthritis and their rheumatologists found that pregnancy is not discouraged and usually goes well, but women rated their worry about flares highly, had gaps in knowledge about biologics in pregnancy and delivery, and only a quarter of rheumatologists knew the pregnancy guidelines. The information gap is on both sides of the consultation.
Risk of peripheral artery disease following ankylosing spondylitis, 2012–2023: a nationwide cohort study in South Korea
Scandinavian Journal of Rheumatology
Following 2,846 people with ankylosing spondylitis and ten times as many matched controls in South Korea for four years, AS was linked to a 40 percent higher rate of peripheral artery disease, with the largest excess in women under 60. Circulation in the legs is another thing to keep an eye on, especially for younger women with AS.